Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04581200 · ClinicalTrials.gov registry record · NA

Lift Mobile Mindfulness for COVID-19 Distress Symptoms

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
56
Enrollment target

NCT04581200: Completed NA study, sponsored by Duke University.

NCT04581200 is a NA study that has completed, run by Duke University. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04581200, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

This is a randomized clinical trial (RCT) nested within the NIH PETAL Network's COVID cohort study (BLUE CORAL \[Biology and Longitudinal Epidemiology: COVID Observational Study\]) of patients hospitalized for COVID-19-related illness. COVID-19 patients enrolled in BLUE CORAL with elevated distress symptoms 1 month post-discharge will be randomized to either the Lift mobile app intervention or a usual care control.

Primary Outcome

Depression symptoms. Scores range from 0 (better) to 27 (worse)

Interventions

  • BEHAVIORAL Lift

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2021-01-25
Est. Completion 2022-05-30
Phase NA
Duke University

1,725 total trials

What the finished NCT04581200 record still lists

NCT04581200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Lift is the first listed.

NCT04581200 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04581200 about?

NCT04581200 is a clinical study titled "Lift Mobile Mindfulness for COVID-19 Distress Symptoms". This is a randomized clinical trial (RCT) nested within the NIH PETAL Network's COVID cohort study (BLUE CORAL \[Biology and Longitudinal Epidemiology: COVID Observational Study\]) of patients hospitalized for COVID-19-related illness. COVID-19 patients enrolled in BLUE CORAL with elevated distress ...

What is the current status of trial NCT04581200?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2021-01-25. Estimated completion is 2022-05-30.

What interventions are being tested in trial NCT04581200?

The interventions under investigation include: Lift (BEHAVIORAL).

Who is sponsoring clinical trial NCT04581200?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04581200's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04581200, the US trial registry maintained by the National Library of Medicine. NCT04581200 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.